Hot Net Payout Yield Stocks To Watch Right Now

Investors in the fertilizer industry have something serious to think about. One of the leading nutrient producers, Agrium (NYSE: AGU  ) , is hanging up on two expansion projects -- It has suspended development work on a greenfield project in the U.S. Midwest area, while dropping plans�to expand an existing plant in Alberta.

They weren't just any plans. The projects would have added more than 30% to Agrium's annual nitrogen production capacity, which currently stands at 5.5 million tonnes. Nitrogen is Agrium's primary product and, as the most widely applied nutrient, has tremendous growth potential, particularly in the U.S. More than 50% of the nitrogen consumed in the U.S. last year was comprised of offshore imports. According to Agrium's recent investor presentation, 12 to 14 new nitrogen plants will be needed if the U.S. were to become self-sufficient. So why did Agrium back off its plans despite the opportunities? The answers might surprise you.

Problem of too many
One reason why Agrium put the projects on hold is similar capacity expansion plans by rivals. That might sound as if Agrium is giving in to peer pressure; yet, its concerns may be justified.

Top 10 Defensive Stocks To Buy For 2015: Coinstar Inc.(CSTR)

Coinstar, Inc., through its subsidiaries, provides automated retail solutions primarily in the United States, Canada, Puerto Rico, Ireland, and the United Kingdom. The company owns and operates self-service Redbox kiosks that enable consumers to rent or purchase movies and video games; and self-service coin-counting kiosks where consumers can convert their coin to cash, a gift card, or an E-certificate. It also engages in identifying, evaluating, building, and developing new self-service concepts in the automated retail space, which includes coffee, refurbished electronics, and photo self-service concepts. As of December 31, 2011, the company had 35,400 Redbox kiosks in 29,300 locations and 20,200 coin-counting kiosks in 19,900 locations primarily in supermarkets, drug stores, mass merchants, financial institutions, convenience stores, and restaurants. Coinstar, Inc. was founded in 1991 and is headquartered in Bellevue, Washington.

Advisors' Opinion:

• [By Canadian Value]

  Position % of Fund Assets 1) First American Financial Corp. (FAF) 7.0% 2) Apple, Inc. (AAPL) 6.5% 3) Coinstar, Inc. (CSTR) 4.8% 4) EMC Corp. (EMC) 4.4% 5) Coach, Inc. (COH) 4.4% 6) Kohl's Corp. (KSS) 4.1% 7) Blucora, Inc. (BCOR) 4.0% 8) Tetra Tech, Inc. (TTEK) 3.1% 9) OM Group, Inc. (OMG) 3.0% 10) American International Group, Inc. (AIG) 2.8% TOTAL 44.1% One area that we believe still offers some value in the market is in high quality, large��ap technology stocks that may be momentarily out��f��avor as they transition from rapid growth to slower growth. In particular, we become interested when that transition is also accompanied by a change in capital allocation policies designed to return more cash to shareholders in the form of dividends and share repurchases. We believe that Apple and EMC are two of the absolute highest quality technology businesses in the world and both have recently announced very material, shareholder��friendly changes to how they will allocate capital.

Hot Net Payout Yield Stocks To Watch Right Now: Opko Health Inc(OPK)

OPKO Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies primarily in the United States, Chile, and Mexico. It provides a range of solutions, including molecular diagnostics tests, proprietary pharmaceuticals, and vaccines to diagnose, treat, and prevent neurological disorders, infectious diseases, oncology, and ophthalmologic diseases. The company offers molecular diagnostic platform technology for the rapid identification of molecules or immunobiomarkers; Alzheimer?s test for Alzheimer?s diagnostic; and protein-based influenza vaccines to provide multi-season and multi-strain protection against various influenza virus strains, such as seasonal influenza strains, as well as global influenza pandemic strains which include swine flu, and avian flu. It also offers Oligonucleotide Therapeutics for the treatment of various illnesses, including cancer, heart disease, metabolic disorders, and genetic anomalies; and oligosaccharide for asthma and chronic obstructive pulmonary diseases. In addition, the company provides Rolapitant, a potent and antagonist; neurokinin-1, which has completed Phase II clinical trials for prevention of chemotherapy induced nausea and vomiting, and post-operative induced nausea and vomiting; and SCH 900978 that has completed Phase II clinical trials for chronic cough. Further, it offers bevasiranib, a drug candidate for the treatment of Wet AMD; and develops Aquashunt, a shunt to be used in the treatment of glaucoma. Additionally, the company involves in the development, commercialization, and sale of ophthalmic diagnostic and imaging systems, and instrumentation products. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Advisors' Opinion:

• [By James E. Brumley]

  Look out Roche Holding Ltd. (OTCMKTS:RHHBY), and Opko Health Inc. (NYSE:OPK) - you're on notice too. There's a new player in the human growth hormone arena, and it may have built the proverbial better mousetrap. Versartis Inc. (NASDAQ:VSAR) only went public in late March, but with the dust from that IPO settling, it's already becoming clear that VSAR - admittedly a one-trick pony - could pose a real threat to OPK and RHHBY... at least on the human growth hormone front.

• [By Roberto Pedone]

  Another healthcare player that insiders are jumping into here is Opko Health (OPK), which is a multi-national pharmaceutical and diagnostics company. Insiders are buying this stock into big time strength, since shares are up 76% in 2013.

  Opko Health has a market cap of $3.4 billion and an enterprise value of $3.5 billion. This stock trades at a premium valuation, with a price-to-sales of 38.01 and a price-to-book at 4.01. Its estimated growth rate for this year is -218.2%. This is not a cash-rich company, since the total cash position on its balance sheet is $180.84 million and its total debt is $226.74 million.

  The CEO just bought 19,400 shares, or about $171,000 worth of stock, at $8.79 to $8.90 per share. The same CEO also just bought 13,000 shares, or about $117,000 worth of stock, at $8.99 to $9.04 per share.

  From a technical perspective, OPK is currently trending above its 200-day moving average and below its 50-day moving average, which is neutral trendwise. This stock has been downtrending over the last few weeks, with shares falling from its high of $11.64 to its recent low of $8.17 a share. During that downtrend, shares of OPK have been making mostly lower highs and lower lows, which is bearish technical price action.

  If you're in the bull camp on OPK, then I would look for long-biased trades as long as this stock is trending above its 200-day at $8.31 or above more key support at $8.17, and then once it breaks out above some near-term overhead resistance at $9.20 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 5.53 million shares. If that breakout hits soon, then OPK will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day of $10.06 a share to $11.64 a share.

• [By GuruFocus]

  SVP & CFO Nimish S Bhatt bought 364 shares of CLMS stock on 11/20/2013 at the average price of 10.47. Nimish S Bhatt owns at least 90,543 shares after this. The price of the stock has increased by 14.52% since.

  Opko Health, Inc. (OPK): CEO & Chairman, 10% Owner Phillip Md Et Al Frost Bought 62,100 Shares

  CEO & Chairman, 10% Owner of Opko Health, Inc. (OPK) Phillip Md Et Al Frost bought 62,100 shares during the past week at an average price of $8.57. Opko Health, Inc. was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics, Inc. Opko Health, Inc. has a market cap of $3.5 billion; its shares were traded at around $8.57 with and P/S ratio of 30.30.

Hot Net Payout Yield Stocks To Watch Right Now: iShares Transportation Average ETF (IYT)

iShares Dow Jones Transportation Average Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones Transportation Average Index (the Index). The Index measures the performance of the transportation sector of the United States equity market, and includes companies in primary groups, such as airlines, trucking, railroads, air freight, transportation services and industrial services.

The Index is subset of the Dow Jones U.S Total Market Index. The components stocks are weighted based on the price of the component securities, with the highest priced securities generally having higher weighting in the Index. The Index is adjusted to reflect changes in capitalization resulting from mergers, acquisitions, stock rights, substitutions and other capital events. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By Chad Fraser] 2013 was a strong year for railroad stocks: the iShares Transportation ETF (NYSE: IYT), about the closest you can get to a gauge for the industry (roughly 30% of the fund’s portfolio is devoted to railway operators) gained 39% during the year.

  That’s miles ahead of the Dow Jones Industrials (up 26%) and the S&P 500 (up 29%).

Hot Net Payout Yield Stocks To Watch Right Now: iShares S&P GSCI Commodity-Indexed Trust (GSG)

iShares S&P GSCI Commodity-Indexed Trust (the Trust), formerly iShares GSCI Commodity-Indexed Trust, issues units of beneficial interest, called Shares, representing fractional undivided beneficial interests in its net assets. Substantially all of the assets of the Trust consist of interests in the iShares S&P GSCI Commodity-Indexed Investing Pool LLC (the Investing Pool). The investment objective of the Trust is to seek investment results, through its investment in the Investing Pool, which correspond generally to the performance of the S&P GSCI Total Return Index (the Index). The Investing Pool is a limited liability company. The Investing Pool holds long positions in CERFs, which are futures contracts listed on the Chicago Mercantile Exchange, which have a term of approximately five years after listing and whose settlement at expiration is based on the value of the S&P GSCI Excess Return Index, or S&P GSCI-ER, at that time.

The Index is intended to reflect the performance of a diversified group of commodities. The Index reflects the value of an investment in the S&P GSCI-ER together with a Treasury bill return. The S&P GSCI-ER reflects the returns that are potentially available through a rolling uncollateralized investment in the contracts comprising the S&P GSCI. Barclays Global Investors International, Inc. is the sponsor of the Trust and the manager of the Investing Pool. Barclays Global Investors, N.A. is the trustee of the Trust.

Advisors' Opinion:

• [By Adam J. Wiederman]

  Getty Images Bitcoin made headlines last year when the value of all outstanding pieces of the electronic currency reached nearly $10 billion. It's not just speculators drawn to the new currency. Many businesses are also attempting to cash in on this growth: Several public companies, including Zynga (ZNGA) and Overstock.com (OSTK), accept Bitcoins as a form of payment. Venture capitalist Marc Andreessen's firm has invested nearly $50 million in Bitcoin-related ventures, and it is looking to invest even more. And the Winklevoss twins -- who notoriously accused Facebook's (FB) Mark Zuckerberg of stealing their idea -- have been "in dialogue" with the SEC about opening the first Bitcoin exchange-traded fund, according to Bloomberg. Yet a new survey from TheStreet.com (TST) reveals that 76 percent of consumers are not familiar with Bitcoin -- and 79 percent would never consider owning a currency like it. Does this signal opportunity for savvy investors? Or is this a fad you'd be wise to avoid? The Basics of Bitcoin Bitcoin is a completely unregulated form of currency developed by an anonymous Japanese programmer (according to some apocryphal claims) as a completely digital, peer-to-peer payment system that is independent of national currencies (which, Bitcoin users argue, are all subject to the riskiness of the underlying country). Bitcoins are rewarded throughout the day to a "Bitcoin miner" whose computer solves a series of algorithms quicker than other miners. The puzzles become more difficult over time, so the calculations take longer and the computations require more computing power. There will eventually be a total of 21 million Bitcoins (12.4 million are in circulation today) and we won't reach the point that they are effectively "mined out" until 2040. The value of a Bitcoin is supposed to be market-driven, meaning they're worth whatever the two parties in a transaction value them as. For example, in one of the original Bitcoin transactions, a "mi